scholarly article | Q13442814 |
review article | Q7318358 |
P6179 | Dimensions Publication ID | 1007532869 |
P356 | DOI | 10.1023/A:1023420432020 |
P698 | PubMed publication ID | 12841348 |
P50 | author | Grant N. Pierce | Q39601044 |
P2093 | author name string | Satoru Hirono | |
P2860 | cites work | Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice | Q37887366 |
Chlamydia pneumoniae multiplies in human endothelial cells in vitro | Q37889130 | ||
Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease | Q37894988 | ||
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 | ||
ISOLATION FROM NORMAL MICE OF A PNEUMOTROPIC VIRUS WHICH FORMS ELEMENTARY BODIES. | Q42235132 | ||
Chlamydia pneumoniae and coronary heart disease | Q57953474 | ||
Does atherosclerosis have an infectious etiology? | Q71493511 | ||
Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. | Q22065998 | ||
Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells | Q33667974 | ||
The role of Chlamydia pneumoniae in cardiovascular disease | Q33817488 | ||
Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages | Q33842925 | ||
The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae | Q33843538 | ||
Interactions of Chlamydia pneumoniae with human endothelial cells | Q33935050 | ||
Chlamydia, inflammation, and atherogenesis | Q33935060 | ||
Mouse models of C. pneumoniae infection and atherosclerosis | Q33935077 | ||
Effect of Chlamydia trachomatis infection on atherosclerosis in apolipoprotein E-deficient mice | Q34005431 | ||
Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice | Q34007947 | ||
Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old) | Q34086738 | ||
Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis | Q34620005 | ||
Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells | Q35488540 | ||
Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis | Q35764383 | ||
In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae | Q36524413 | ||
Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice | Q37873686 | ||
Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation | Q37873723 | ||
Human monocyte-derived insulin-like growth factor-2 enhances the infection of human arterial endothelial cells by Chlamydia pneumoniae | Q37874441 | ||
Monocyte-endothelial cell coculture enhances infection of endothelial cells with Chlamydia pneumoniae | Q37876903 | ||
In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells | Q37877535 | ||
Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice | Q37878302 | ||
Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s). | Q37878378 | ||
Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae. | Q37878639 | ||
Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes | Q37879018 | ||
Chlamydia pneumoniae in vascular tissue | Q37879489 | ||
Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression | Q37880399 | ||
Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse | Q37881023 | ||
Distribution of Chlamydia pneumoniae infection in the athersclerotic carotid artery | Q37881215 | ||
Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells | Q37881299 | ||
Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research | Q37881887 | ||
Chronic infections and coronary heart disease: is there a link? | Q37882245 | ||
Murine models of Chlamydia pneumoniae infection and atherosclerosis | Q37883205 | ||
In vitro infection of smooth muscle cells by Chlamydia pneumoniae. | Q37883558 | ||
Rabbit model for Chlamydia pneumoniae infection | Q37883934 | ||
P433 | issue | 1-2 | |
P921 | main subject | atherosclerosis | Q12252367 |
Chlamydia pneumoniae | Q62869737 | ||
P304 | page(s) | 91-95 | |
P577 | publication date | 2003-04-01 | |
P1433 | published in | Molecular and Cellular Biochemistry | Q1573176 |
P1476 | title | Dissemination of Chlamydia pneumoniae to the vessel wall in atherosclerosis | |
P478 | volume | 246 |
Q28196475 | Chlamydia pneumoniae, heat shock proteins 60 and risk of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes: a prospective study |
Q37853901 | Chlamydophila pneumoniae infection leads to smooth muscle cell proliferation and thickening in the coronary artery without contributions from a host immune response |
Search more.